Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

102
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
102
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

157
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
157
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.6K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K
Clinical Trials01:16

Clinical Trials

10.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.0K
Data Validation01:15

Data Validation

456
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
456

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cholesterol-dependent modulation of β-amyloid 1-40 peptide aggregation by membrane organization.

Journal of colloid and interface science·2026
Same author

Drug-Coated Balloon Only Percutaneous Coronary Intervention for De-Novo Chronic Total Occlusion: Insights From the Multicenter International CTO-DENOVO Registry.

The American journal of cardiology·2026
Same author

Crofton Risk and Relative Transactional Entropy.

Entropy (Basel, Switzerland)·2026
Same author

Lipid Shape as a Membrane Activity Modulator of a Fusogenic Antimicrobial Peptide.

Journal of chemical information and modeling·2025
Same author

A Non-Stochastic Special Model of Risk Based on Radon Transform.

Entropy (Basel, Switzerland)·2024
Same author

The Renovation of Good Clinical Practice: A Framework for Key Components of ICH E8.

Therapeutic innovation & regulatory science·2023

Related Experiment Video

Updated: Dec 10, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.2K

Quality Tolerance Limits: Framework for Successful Implementation in Clinical Development.

Ruma Bhagat1, Lukasz Bojarski2, Soazig Chevalier3

  • 1Roche, 1 DNA Way, South San Francisco, CA, 94404, USA. bhagat.ruma@gene.com.

Therapeutic Innovation & Regulatory Science
|September 5, 2020
PubMed
Summary
This summary is machine-generated.

The International Council for Harmonisation E6(R2) guideline introduced Quality Tolerance Limits (QTLs) to enhance clinical trial quality management. TransCelerate developed a framework to guide the implementation of QTLs, ensuring participant safety and data reliability.

Keywords:
KRIKey risk indicatorsQMSQTLQuality management systemQuality tolerance limits

More Related Videos

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.4K
A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

842

Related Experiment Videos

Last Updated: Dec 10, 2025

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.2K
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.4K
A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

842

Area of Science:

  • Clinical Research Quality Management
  • Regulatory Science
  • Pharmaceutical Development

Background:

  • The International Council for Harmonisation (ICH) E6(R2) guideline introduced Quality Tolerance Limits (QTLs) to modernize clinical trial quality control.
  • QTLs provide measurable feedback on clinical trial parameters, enhancing visibility into participant protection and data reliability.
  • Previously, these parameters were primarily used by statistical and clinical functions for tracking trial progress.

Purpose of the Study:

  • To introduce and explain the concept of Quality Tolerance Limits (QTLs) as mandated by the ICH E6(R2) guideline.
  • To present the TransCelerate Quality Tolerance Limits (QTL) Framework designed to guide industry sponsors and agents in implementing QTLs.
  • To support the improvement of clinical research quality, ensuring participant safety and data integrity while meeting Health Authority expectations.

Main Methods:

  • Development of a comprehensive framework by TransCelerate to facilitate the industry-wide implementation of QTLs.
  • The framework provides guidance on applying QTLs in alignment with ICH E6(R2) Sections 5.0.4 and 5.0.7.
  • Includes considerations for setting appropriate QTL thresholds to maximize efficiency and minimize confusion.

Main Results:

  • The implementation of QTLs elevates key trial parameters within the Quality Management System (QMS).
  • This elevation increases cross-functional and enterprise-wide visibility of critical quality indicators.
  • The TransCelerate framework aims to streamline QTL implementation, enhancing the reliability of clinical trial results.

Conclusions:

  • The ICH E6(R2) guideline and the TransCelerate QTL Framework represent a significant advancement in clinical trial quality management.
  • Effective implementation of QTLs is crucial for safeguarding participants and ensuring the reliability of trial outcomes.
  • The framework promotes consistent and efficient application of QTLs across the industry, aligning with regulatory expectations.